Alembic Pharmaceuticals receives U.S. FDA approval for Paliperidone extended-release tablets Read more
Bristol Myers Squibb’s cell therapy gets USFDA nod for relapsed or refractory follicular lymphoma Read more
Alembic Pharma receives USFDA’s final approval for Fesoterodine Fumarate extended-release tablets Read more